These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35687982)

  • 21. Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529).
    Chun JY; Jeong H; Kim Y
    BMC Med; 2022 Nov; 20(1):451. PubMed ID: 36419108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative epidemiology of outbreaks caused by SARS-CoV-2 Delta and Omicron variants in China.
    Peng L; Huang X; Wang C; Xin H; Cowling BJ; Wu P; Tsang TK
    Epidemiol Infect; 2024 Mar; 152():e43. PubMed ID: 38500342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach.
    Yen AM; Chen TH; Chang WJ; Lin TY; Jen GH; Hsu CY; Wang ST; Dang H; Chen SL
    JMIR Public Health Surveill; 2022 Nov; 8(11):e40866. PubMed ID: 36265134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.
    Pulliam JRC; van Schalkwyk C; Govender N; von Gottberg A; Cohen C; Groome MJ; Dushoff J; Mlisana K; Moultrie H
    Science; 2022 May; 376(6593):eabn4947. PubMed ID: 35289632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.
    Taylor CA; Whitaker M; Anglin O; Milucky J; Patel K; Pham H; Chai SJ; Alden NB; Yousey-Hindes K; Anderson EJ; Teno K; Reeg L; Como-Sabetti K; Bleecker M; Barney G; Bennett NM; Billing LM; Sutton M; Talbot HK; McCaffrey K; Havers FP;
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):466-473. PubMed ID: 35324880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitals.
    Leiner J; Pellissier V; Hohenstein S; König S; Schuler E; Möller R; Nachtigall I; Bonsignore M; Hindricks G; Kuhlen R; Bollmann A
    BMC Infect Dis; 2022 Oct; 22(1):802. PubMed ID: 36303111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delineating the Spread and Prevalence of SARS-CoV-2 Omicron Sublineages (BA.1-BA.5) and Deltacron Using Wastewater in the Western Cape, South Africa.
    Johnson R; Mangwana N; Sharma JR; Muller CJF; Malemela K; Mashau F; Dias S; Ramharack P; Kinnear C; Glanzmann B; Viraragavan A; Louw J; Surujlal-Naicker S; Nkambule S; Webster C; Mdhluli M; Gray G; Mathee A; Preiser W; Vorster A; Dalvie S; Street R
    J Infect Dis; 2022 Oct; 226(8):1418-1427. PubMed ID: 36017801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea.
    Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW
    J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.
    Wang L; Cheng G
    J Med Virol; 2022 Apr; 94(4):1728-1733. PubMed ID: 34897752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing the incubation period, serial interval, and infectiousness profile between SARS-CoV-2 Omicron and Delta variants.
    Guo Z; Zhao S; Mok CKP; So RTY; Yam CHK; Chow TY; Chan TCP; Wei Y; Jia KM; Wang MH; Chong KC; Yeoh EK
    J Med Virol; 2023 Mar; 95(3):e28648. PubMed ID: 36892159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods.
    Shoji K; Tsuzuki S; Akiyama T; Matsunaga N; Asai Y; Suzuki S; Iwamoto N; Funaki T; Yamada M; Ozawa N; Yamaguchi K; Miyairi I; Ohmagari N
    J Infect Chemother; 2023 Jan; 29(1):33-38. PubMed ID: 36103949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The case fatality rate of COVID-19 during the Delta and the Omicron epidemic phase: A meta-analysis.
    Kim K; Cho K; Song J; Rahmati M; Koyanagi A; Lee SW; Yon DK; Il Shin J; Smith L
    J Med Virol; 2023 Feb; 95(2):e28522. PubMed ID: 36691933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronavirus disease 2019 transmission and symptoms in young children during the severe acute respiratory syndrome coronavirus 2 Delta variant and Omicron variant outbreaks.
    Akaishi T; Ishii T
    J Int Med Res; 2022 May; 50(5):3000605221102079. PubMed ID: 35619217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is Omicron the last SARS-CoV-2 Variant of Concern?
    Rahimi F; Talebi Bezmin Abadi A
    Arch Med Res; 2022 Apr; 53(3):336-338. PubMed ID: 35093242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: A world-wide review.
    Wang C; Liu B; Zhang S; Huang N; Zhao T; Lu QB; Cui F
    J Med Virol; 2023 Jan; 95(1):e28118. PubMed ID: 36056540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron).
    Yang W; Shaman JL
    Elife; 2022 Aug; 11():. PubMed ID: 35943138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0-3.3 Days Can Be Explained by Immune Evasion.
    Grabowski F; Kochańczyk M; Lipniacki T
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective Observational Study of Complete Blood Count (CBC) Parameters and ICU Mortality of COVID-19 Disease in Delta Variant and Omicron Variant in a Community-Based Hospital in New York City.
    Yadav R; Yadav V; Pokhriyal S; Zahid U; Gandhi A
    Cureus; 2023 Feb; 15(2):e34894. PubMed ID: 36925973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immune evasion ability of Delta variant is comparable to that of Beta variant in South Africa.
    He D; Chen B; Zhao S; Stone L
    BMC Public Health; 2023 Mar; 23(1):511. PubMed ID: 36927400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.